tiprankstipranks
Trending News
More News >
Essex Bio-Technology Limited (HK:1061)
:1061
Hong Kong Market

Essex Bio-Technology (1061) Ownership - Who Owns Essex Bio-Technology?

Compare
0 Followers

Essex Bio-Technology (1061) Ownership Overview

0.62%0.14%99.25%
0.62%
Mutual Funds
0.14% ETFs
99.25% Public Companies and
Individual Investors
The ownership structure of Essex Bio-Technology (HK:1061) stock is a mix of institutional, retail, and individual investors. , and 99.25% is owned by Public Companies and Individual Investors.
The ownership structure of Essex Bio-Technology (HK:1061) stock is a mix of institutional, retail, and individual investors. Approximately 99.38% of the company’s stock is owned by Institutional Investors, 0.62% is owned by Insiders

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,469,000Institution0.61%1,814,287
504,000Institution0.09%263,592
273,000Institution0.05%142,779
21,000Institution<0.01%10,983

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,469,000Institution0.61%1,814,287
21,000Institution<0.01%10,983

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
322,000Institution0.06%172,894
256,000Institution0.05%138,108
146,000Institution0.03%78,393
36,000Institution<0.01%19,330
17,000Institution<0.01%9,171
1,334Institution<0.01%568

FAQ

Who Owns Essex Bio-Technology Limited (HK:1061)?
Currently, no data Available
What percentage of Essex Bio-Technology Limited (HK:1061) stock is held by institutional investors?
Currently, no data Available
What percentage of Essex Bio-Technology Limited (HK:1061) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.25% of Essex Bio-Technology Limited (HK:1061) stock is held by retail investors.
    Who owns the most shares of Essex Bio-Technology Limited (HK:1061)?
    DFA INVESTMENT DIMENSIONS GROUP INC owns the most shares of Essex Bio-Technology Limited (HK:1061).
      What is the significance of the ownership structure for a publicly traded company?
      The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.